Citation:Studer UE, Whelan P, Albrecht W, Casselman J, de Reijke T, Hauri D, et al 2006

Citation

Studer UE, Whelan P, Albrecht W, Casselman J, de Reijke T, Hauri D, et al. Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891. J Clin Oncol 2006 Apr 20;24(12):1868-76 Available from: http://www.ncbi.nlm.nih.gov/pubmed/16622261.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Studer UE, Whelan P, Albrecht W, Casselman J, de Reijke T, Hauri D, et al 2006	For men with biopsy-diagnosed prostate cancer, for which patients (based on diagnostic and clinical criteria) does watchful waiting achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment or active surveillance?	Katherine Sheridan	completed
Studer UE, Whelan P, Albrecht W, Casselman J, de Reijke T, Hauri D, et al 2006 2	For men with biopsy-diagnosed prostate cancer, for which patients (based on diagnostic and clinical criteria) does watchful waiting achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment or active surveillance?	Dr Albert Chetcuti BTech(Biotech) Hons, PhD	completed

Compare quality appraisals for each clinical question

• [[Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does watchful waiting achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment or active surveillance?|]] (compare critical appraisals)
• [[Clinical question:For men with biopsy-diagnosed prostate cancer, for which patients does watchful waiting achieve equivalent or better outcomes in terms of length and quality of life than definitive treatment or active surveillance?|]] (compare critical appraisals)

Cited by

1. Watchful waiting
2. What should be done for patients with locally advanced disease who are not suitable candidates for surgery or radiotherapy – primary androgen deprivation at diagnosis or wait until clinical progression (localized or metastatic) - Timing?
3. What should be done for patients with locally advanced disease who are not suitable candidates for surgery or radiotherapy – primary androgen deprivation at diagnosis or wait until clinical progression (localized or metastatic)?

EORTC 30891